James W Antoon1,2, Carlos G Grijalva3, Alison G Grisso4, Cosby A Stone5, Jakobi Johnson1, Justine Stassun1, Allison E Norton6, Sunil Kripalani7, Derek J Williams1. 1. Division of Hospital Medicine, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee. 2. Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee. 3. Department of Health Policy. 4. Department of Pharmacy, Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee. 5. Division of Allergy & Immunology, Departments of Medicine. 6. Pediatrics and Medicine. 7. Division of General Internal Medicine and Public Health, Department of Medicine, and Center for Clinical Quality and Implementation Research, Vanderbilt University Medical Center, Nashville, Tennessee.
Abstract
BACKGROUND: Penicillin allergy labels are often inaccurate in children and removing unnecessary labels results in improved outcomes and lower health care costs. Although the hospital setting is a frequent point of contact for children, strategies to evaluate penicillin allergies in the hospital are lacking. METHODS: We performed a prospective pilot study to determine the feasibility of a centralized, pharmacy-led approach to penicillin allergy evaluation. Children with a reported history of penicillin allergy admitted to our children's hospital were risk-stratified and those stratified as low-risk underwent a single-dose oral challenge by a central pharmacist, regardless of the need for antibiotics. After the completion of each patient's delabeling process, surveys were distributed to health care personnel involved in the patient's care to collect perceptions on the acceptability, appropriateness, and feasibility of this intervention. Measures were scored by using a 5-point Likert scale. RESULTS: Of the 23 patients who screened as low-risk, 20 underwent a penicillin allergy evaluation and an oral challenge. Of these, the penicillin allergy label was removed in 19 (95%) patients (Fig 1). The median age was 7 years (range 11 months-18 years). Participants rated the risk stratification and delabeling favorably overall, with high ratings on all 3 implementation measures: acceptability (mean 4.55, ± standard deviation [STD] 0.65), appropriateness (mean 4.58, STD ± 0.6), and feasibility (mean 4.51, STD ± 0.73). Measures of acceptability, appropriateness, and feasibility remained high when stratified by health care worker type and provider type. CONCLUSIONS: Our findings provide support for systemic implementation of penicillin allergy delabeling strategies in hospitalized children.
BACKGROUND: Penicillin allergy labels are often inaccurate in children and removing unnecessary labels results in improved outcomes and lower health care costs. Although the hospital setting is a frequent point of contact for children, strategies to evaluate penicillin allergies in the hospital are lacking. METHODS: We performed a prospective pilot study to determine the feasibility of a centralized, pharmacy-led approach to penicillin allergy evaluation. Children with a reported history of penicillin allergy admitted to our children's hospital were risk-stratified and those stratified as low-risk underwent a single-dose oral challenge by a central pharmacist, regardless of the need for antibiotics. After the completion of each patient's delabeling process, surveys were distributed to health care personnel involved in the patient's care to collect perceptions on the acceptability, appropriateness, and feasibility of this intervention. Measures were scored by using a 5-point Likert scale. RESULTS: Of the 23 patients who screened as low-risk, 20 underwent a penicillin allergy evaluation and an oral challenge. Of these, the penicillin allergy label was removed in 19 (95%) patients (Fig 1). The median age was 7 years (range 11 months-18 years). Participants rated the risk stratification and delabeling favorably overall, with high ratings on all 3 implementation measures: acceptability (mean 4.55, ± standard deviation [STD] 0.65), appropriateness (mean 4.58, STD ± 0.6), and feasibility (mean 4.51, STD ± 0.73). Measures of acceptability, appropriateness, and feasibility remained high when stratified by health care worker type and provider type. CONCLUSIONS: Our findings provide support for systemic implementation of penicillin allergy delabeling strategies in hospitalized children.
Authors: Cosby A Stone; Joanna L Stollings; Christopher J Lindsell; Mary Lynn Dear; Reagan B Buie; Todd W Rice; Elizabeth J Phillips Journal: Am J Respir Crit Care Med Date: 2020-06-15 Impact factor: 21.405
Authors: James W Antoon; Matt Hall; Alison Herndon; Alison Carroll; My-Linh Ngo; Katherine L Freundlich; Justine C Stassun; Patricia Frost; David P Johnson; Swati B Chokshi; Charlotte M Brown; Whitney L Browning; James A Feinstein; Carlos G Grijalva; Derek J Williams Journal: Pediatrics Date: 2020-10-09 Impact factor: 7.124
Authors: David Vyles; Asriani Chiu; John Routes; Mariana Castells; Elizabeth J Phillips; Jennifer Kibicho; David C Brousseau Journal: Pediatrics Date: 2018-05 Impact factor: 7.124
Authors: David Vyles; James W Antoon; Allison Norton; Cosby A Stone; Jason Trubiano; Alexandra Radowicz; Elizabeth J Phillips Journal: Ann Allergy Asthma Immunol Date: 2020-03-26 Impact factor: 6.347
Authors: David Vyles; Juan Adams; Asriani Chiu; Pippa Simpson; Mark Nimmer; David C Brousseau Journal: Pediatrics Date: 2017-07-03 Impact factor: 7.124
Authors: Susan E Coffin; Francisca Abanyie; Kristina Bryant; Joseph Cantey; Anthony Fiore; Stephanie Fritz; Judith Guzman-Cottrill; Adam L Hersh; W Charles Huskins; Larry K Kociolek; Matthew Kronman; Ebbing Lautenbach; Grace Lee; Matthew Linam; Latania K Logan; Aaron Milstone; Jason Newland; A Christine Nyquist; Debra L Palazzi; Sameer Patel; Karen Puopolo; Sujan C Reddy; Lisa Saiman; Thomas Sandora; Andi L Shane; Michael Smith; Pranita D Tamma; Theoklis Zaoutis; Danielle Zerr; Jeffrey S Gerber Journal: Infect Control Hosp Epidemiol Date: 2020-11-26 Impact factor: 3.254